Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Although major depressive disorder is primarily considered a mood disorder, depressed patients commonly present with clinically significant cognitive dysfunction that may add to their functional disability. This review paper summarizes the available preclinical data on the effects of antidepressants, including monoamine reuptake inhibitors and the multimodal antidepressant vortioxetine, in behavioral tests of cognition such as cognitive flexibility, attention, and memory, or in potentially cognition-relevant mechanistic assays such as electroencephalography, in vivo microdialysis, in vivo or in vitro electrophysiology, and molecular assays related to neurogenesis or synaptic sprouting. The available data are discussed in context with clinically relevant doses and their relationship to target occupancy levels, in order to evaluate the translational relevance of preclinical doses used during testing. We conclude that there is preclinical evidence suggesting that traditional treatment with monoamine reuptake inhibitors can induce improved cognitive function, for example in cognitive flexibility and memory, and that the multimodal-acting antidepressant vortioxetine may have some advantages by comparison to these treatments. However, the translational value of the reviewed preclinical data can be questioned at times, due to the use of doses outside the therapeutically-relevant range, the lack of data on target engagement or exposure, the tendency to investigate acute rather than long term antidepressant administration, and the trend towards using normal rodents rather than models with translational relevance for depression. Finally, several suggestions are made for advancing this field, including expanded use of target occupancy assessments in preclinical and clinical experiments, and the use of translationally valuable techniques such as electroencephalography.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
The stressed hippocampus, synaptic plasticity and lost memories
Kim, J. J., & Diamond, D. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn849 · Cited by 1,543
Silva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.127 · Cited by 1,462
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Saxe, M. D., Battaglia, F., Wang, J.-W., Malleret, G., David, D. J., Monckton, J. E., Garcia, A. D. R., Sofroniew, M. V., Kandel, E. R., Santarelli, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607207103 · Cited by 1,020
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
A meta-analysis of depression severity and cognitive function
McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956
Neurogenesis may relate to some but not all types of hippocampal‐dependent learning
Shors, T. J., Townsend, D. A., Zhao, M., Kozorovitskiy, Y., & Gould, E. (2002) · Hippocampus · doi:10.1002/hipo.10103 · Cited by 853
The functional significance of delta oscillations in cognitive processing
Harmony, T. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00083 · Cited by 788
Research works printed but not linked: 141
- Alkam, 2011, Evaluation of object-based attention in mice, Behav. Brain Res., 220, 185, 10.1016/j.bbr.2011.01.039 · DOI
- Ashby, 1991, 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study, Brain Res., 550, 181, 10.1016/0006-8993(91)91316-S · DOI
- Baarendse, 2012, Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats, Psychopharmacology, 219, 313, 10.1007/s00213-011-2576-x · DOI · Paper page
- Barco, 2011, Genetic approaches to investigate the role of CREB in neuronal plasticity and memory, Mol. Neurobiol., 44, 330, 10.1007/s12035-011-8209-x · DOI
- Basar, 1999, Are cognitive processes manifested in event-related gamma, alpha, theta and delta oscillations in the EEG?, Neurosci. Lett., 259, 165, 10.1016/S0304-3940(98)00934-3 · DOI · Paper page
- Basar, 2000, Brain oscillations in perception and memory, Int. J. Psychophysiol., 35, 95, 10.1016/S0167-8760(99)00047-1 · DOI · Paper page
- Basar, 2001, Gamma, alpha, delta, and theta oscillations govern cognitive processes, Int. J. Psychophysiol., 39, 241, 10.1016/S0167-8760(00)00145-8 · DOI · Paper page
- Basar, 2008, A review of brain oscillations in cognitive disorders and the role of neurotransmitters, Brain Res., 1235, 172, 10.1016/j.brainres.2008.06.103 · DOI · Paper page
- Baune, 2006, The association between depressive mood and cognitive performance in an elderly general population—the MEMO Study, Dement. Geriatr. Cogn. Disord., 22, 142, 10.1159/000093745 · DOI · Paper page
- Beiko, 1997, The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance, Behav. Brain Res., 88, 201, 10.1016/S0166-4328(97)02298-5 · DOI
- Bell, 2003, Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers, Psychopharmacology, 166, 102, 10.1007/s00213-002-1314-9 · DOI
- Benavides-Piccione, 2013, Age-based comparison of human dendritic spine structure using complete three-dimensional reconstructions, Cereb. Cortex, 23, 1798, 10.1093/cercor/bhs154 · DOI · Paper page
- Betry, 2013, The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism, Int. J. Neuropsychopharmacol., 16, 1115, 10.1017/S1461145712001058 · DOI · Paper page
- Bianchi, 2009, Chronic fluoxetine differentially modulates the hippocampal microtubular and serotonergic system in grouped and isolation reared rats, Eur. Neuropsychopharmacol., 19, 778, 10.1016/j.euroneuro.2009.06.005 · DOI
- Biringer, 2005, The association between depression, anxiety, and cognitive function in the elderly general population—the Hordaland health study, Int. J. Geriatr. Psychiatry, 20, 989, 10.1002/gps.1390 · DOI · Paper page
- Bjorvatn, 1995, Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination, Sleep, 18, 451, 10.1093/sleep/18.6.451 · DOI
- Blokland, 2002, Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat, J. Psychopharmacol., 16, 39, 10.1177/026988110201600112 · DOI · Paper page
- Bondi, 2008, Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment, Neuropsychopharmacology, 33, 320, 10.1038/sj.npp.1301410 · DOI · Paper page
- Bordner, 2011, Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex, Exp. Gerontol., 46, 643
- Carlini, 2007, Selective serotonin reuptake inhibitor (fluoxetine) decreases the effects of ghrelin on memory retention and food intake, Regul. Pept., 140, 65, 10.1016/j.regpep.2006.11.012 · DOI
- Carlini, 2012, Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action, Prog. Neuropsychopharmacol. Biol. Psychiatry, 38, 159, 10.1016/j.pnpbp.2012.03.004 · DOI · Paper page
- Chalon, 2005, Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects, Psychopharmacology, 177, 357, 10.1007/s00213-004-1961-0 · DOI
- Conrad, 2010, A critical review of chronic stress effects on spatial learning and memory, Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 742, 10.1016/j.pnpbp.2009.11.003 · DOI · Paper page
- Coppell, 2003, Bi-phasic change in BDNF gene expression following antidepressant drug treatment, Neuropharmacology, 44, 903, 10.1016/S0028-3908(03)00077-7 · DOI · Paper page
- Croarkin, 2011, Evidence for GABAergic inhibitory deficits in major depressive disorder, Neurosci. Biobehav. Rev., 35, 818, 10.1016/j.neubiorev.2010.10.002 · DOI
- Cuadra, 2001, Influence of different antidepressant drugs on the effect of chronic variable stress on restraint-induced dopamine release in frontal cortex, Neuropsychopharmacology, 25, 384, 10.1016/S0893-133X(01)00234-2 · DOI
- Cuadra, 1999, Chronic stress sensitizes frontal cortex dopamine release in response to a subsequent novel stressor: reversal by naloxone, Brain Res. Bull., 48, 303, 10.1016/S0361-9230(98)00179-8 · DOI · Paper page
- Dale, 2013, Vortioxetine (Lu AA21004) disinhibits pyramidal cell output and enhances theta rhythms and long-term plasticity in the hippocampus, Eur. Neuropsychopharmacol., 23, S394, 10.1016/S0924-977X(13)70622-9 · doi:10.1016/s0924-977x(13)70622-9
- David, 2009, Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, 62, 479, 10.1016/j.neuron.2009.04.017 · DOI · Paper page
- Dazzi, 2005, Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress, Eur. Neuropsychopharmacol., 15, 283, 10.1016/j.euroneuro.2004.11.003 · DOI
- Degroot, 2005, Fluoxetine disrupts the integration of anxiety and aversive memories, Neuropsychopharmacology, 30, 391, 10.1038/sj.npp.1300624 · DOI
- Delgado, 1990, Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan, Arch. Gen. Psychiatry, 47, 411, 10.1001/archpsyc.1990.01810170011002 · DOI · Paper page
- Denny, 2012, 4- to 6-week-old adult-born hippocampal neurons influence novelty-evoked exploration and contextual fear conditioning, Hippocampus, 22, 1188, 10.1002/hipo.20964 · DOI · Paper page
- Deschaux, 2011, Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear, Psychopharmacology, 215, 231, 10.1007/s00213-010-2134-y · DOI
- de St Hilaire-Kafi, 1988, Hypnotic action of flunitrazepam in the rat: does 5-HT mechanism play a role?, Neuropharmacology, 27, 1227, 10.1016/0028-3908(88)90024-X · doi:10.1016/0028-3908(88)90024-x
- Di Chiara, 1999, Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression, Biol. Psychiatry, 46, 1624, 10.1016/S0006-3223(99)00236-X · DOI · Paper page
- Dincheva, 2012, Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics, Neuroscientist, 18, 439, 10.1177/1073858411431646 · DOI · Paper page
- Dimpfel, 2003, Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG), Eur. J. Med. Res., 8, 199
- Dotson, 2009, Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study, J. Psychiatry Neurosci., 34, 367, 10.1139/jpn.0948 · DOI · Paper page
- Drew, 2010, Arrest of adult hippocampal neurogenesis in mice impairs single- but not multiple-trial contextual fear conditioning, Behav. Neurosci., 124, 446, 10.1037/a0020081 · DOI · Paper page
- Dringenberg, 2000, Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy, Neurobiol. Aging., 21, 135, 10.1016/S0197-4580(00)00108-1 · DOI
- Driscoll, 2006, The aging hippocampus: a multi-level analysis in the rat, Neuroscience, 139, 1173, 10.1016/j.neuroscience.2006.01.040 · DOI · Paper page
- du Jardin, 2013, Single dose vortioxetine or ketamine but not fluoxetine increases expression of neuroplasticity related genes in the rat prefrontal cortex, Eur. Neuropsychopharmacol., 23, S392, 10.1016/S0924-977X(13)70619-9 · DOI
- Elgersma, 2004, Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition, J. Neurosci., 24, 8410, 10.1523/JNEUROSCI.3622-04.2004 · DOI · Paper page
- Elizalde, 2008, Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment, Psychopharmacology, 199, 1, 10.1007/s00213-007-1035-1 · DOI · Paper page
- El Hage, 2004, Impaired memory following predatory stress in mice is improved by fluoxetine, Prog. Neuropsychopharmacol Biol. Psychiatry, 28, 123, 10.1016/j.pnpbp.2003.09.028 · DOI · Paper page
- Eriksson, 2012, 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors, Neuropharmacology, 63, 1150, 10.1016/j.neuropharm.2012.06.061 · DOI
- Feige, 2002, Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects, Neuropsychopharmacology, 26, 246, 10.1016/S0893-133X(01)00314-1 · DOI
- Finlay, 1997, The effects of stress on central dopaminergic neurons: possible clinical implications, Neurochem. Res., 22, 1387, 10.1023/A:1022075324164 · DOI · Paper page
- Flood, 1987, Fluoxetine enhances memory processing in mice, Psychopharmacology, 93, 36, 10.1007/BF02439584 · DOI
- Gronier, 2003, Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex, Neurosci. Lett., 349, 196, 10.1016/S0304-3940(03)00851-6 · DOI
- Grunbaum-Novak, 2008, Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition, Eur. Neuropsychopharmacol., 18, 431, 10.1016/j.euroneuro.2007.08.004 · DOI
- Guilloux, 2013, Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice, Neuropharmacology, 73, 147, 10.1016/j.neuropharm.2013.05.014 · DOI · Paper page
- Gumuslu, 2013, The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice, Drug. Res., 63, 532, 10.1055/s-0033-1347237 · DOI
- Haddjeri, 2012, Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition, Eur. Neuropsychopharmacol., 22, S303, 10.1016/S0924-977X(12)70462-5 · DOI
- Harvey, 2004, Serotonin and stress: protective or malevolent actions in the biobehavioral response to repeated trauma?, Ann. N. Y. Acad. Sci., 1032, 267, 10.1196/annals.1314.035 · DOI
- Hashimoto, 2007, Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors, Neuropsychopharmacology, 32, 514, 10.1038/sj.npp.1301047 · DOI
- Holick, 2008, Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor, Neuropsychopharmacology, 33, 406, 10.1038/sj.npp.1301399 · DOI · Paper page
- Humpston, 2013, Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task, J. Psychopharmacol., 27, 213, 10.1177/0269881112466182 · DOI
- Ibi, 2008, Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice, J. Neurochem., 105, 921, 10.1111/j.1471-4159.2007.05207.x · DOI · Paper page
- Ivarsson, 2005, Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats, Eur. J. Pharmacol., 522, 63, 10.1016/j.ejphar.2005.08.050 · DOI
- Jans, 2010, The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats, J. Psychopharmacol., 24, 605, 10.1177/0269881108099424 · DOI · Paper page
- Jansen, 1994, The effects of serotonergic drugs on short-term spatial memory in rats, J. Psychopharmacol., 8, 157, 10.1177/026988119400800303 · doi:10.1177/026988119400800303
- Jenkins, 2010, Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat, Neurosci. Lett., 471, 144, 10.1016/j.neulet.2010.01.028 · DOI · Paper page
- Karpova, 2011, Fear erasure in mice requires synergy between antidepressant drugs and extinction training, Science, 334, 1731, 10.1126/science.1214592 · DOI · Paper page
- Katoh, 1995, Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats, J. Pharmacol. Exp. Ther., 272, 1067, 10.1016/S0022-3565(25)24530-X · DOI
- Khawaja, 2004, Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies, J. Neurosci. Res., 75, 451, 10.1002/jnr.10869 · DOI · Paper page
- Knott, 2002, EEG correlates of acute and chronic paroxetine treatment in depression, J. Affect Disord., 69, 241, 10.1016/S0165-0327(01)00308-1 · DOI
- Lader, 1986, The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects, Eur. J. Clin. Pharmacol., 31, 183, 10.1007/BF00606656 · DOI
- Lebron-Milad, 2013, Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction, Behav. Brain Res., 253, 217, 10.1016/j.bbr.2013.07.024 · DOI
- Leiser, 2011, Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research, Biochem. Pharmacol., 81, 1408, 10.1016/j.bcp.2010.10.002 · DOI
- Leiser, 2014, The multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine—a quantitative electroencephalographic study in the rat, Br. J. Pharmacol., 10.1111/bph.12782 · DOI · Paper page
- Li, 2013, Memory impairment in old mice is differentially sensitive to different classes of antidepressants, Eur. Neuropsychopharmacol., 23, S282, 10.1016/S0924-977X(13)70440-1 · DOI
- Lieben, 2004, Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat, Behav. Brain Res., 151, 53, 10.1016/j.bbr.2003.08.002 · DOI
- Lindahl, 2004, Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine, Neuropsychopharmacology, 29, 2065, 10.1038/sj.npp.1300485 · DOI
- Linthorst, 2008, Stress and the brain: solving the puzzle using microdialysis, Pharmacol. Biochem. Behav., 90, 163, 10.1016/j.pbb.2007.09.019 · DOI
- Luthringer, 1996, A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression, Psychopharmacol Bull., 32, 637
- Malatynska, 2012, Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression, Exp. Gerontol., 47, 552, 10.1016/j.exger.2012.04.010 · DOI
- Martinez-Turrillas, 2005, Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment, Neuropharmacology, 49, 1178, 10.1016/j.neuropharm.2005.07.006 · DOI
- Martinez-Turrillas, 2002, Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus, Neuropharmacology, 43, 1230, 10.1016/S0028-3908(02)00299-X · DOI
- Martisova, 2013, Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer׳s disease in adult male rats, Curr. Alzheimer Res., 10, 420, 10.2174/1567205011310040007 · DOI
- Matsumoto, 2005, Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress, Psychopharmacology, 179, 606, 10.1007/s00213-004-2094-1 · DOI
- McIntyre, 2013, Randomized, double-blind, placebo-controlled study of the efficacy of vortioxetine on cognitive dysfunction in adult patients with major depressive disorder (MDD), Neuropsychopharmacology, 38, 380
- Melo, 2012, Antidepressants differentially modify the extinction of an aversive memory task in female rats, Prog. Neuropsychopharmacol. Biol. Psychiatry, 37, 33, 10.1016/j.pnpbp.2012.01.012 · DOI
- Mnie-Filali, 2006, Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity, Neurosci. Lett., 395, 23, 10.1016/j.neulet.2005.10.044 · DOI
- Montezinho, 2010, The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine, Psychopharmacology, 212, 131, 10.1007/s00213-010-1917-5 · DOI
- Mork, 2013, Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats, Pharmacol. Biochem. Behav., 105, 41, 10.1016/j.pbb.2013.01.019 · DOI · Paper page
- Neckelmann, 1996, Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration, Behav. Brain. Res., 79, 183, 10.1016/0166-4328(96)00013-7 · DOI
- Nibuya, 1996, Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus, J. Neurosci., 16, 2365, 10.1523/JNEUROSCI.16-07-02365.1996 · DOI · Paper page
- Nicholson, 1986, 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man, Neuropharmacology, 25, 1079, 10.1016/0028-3908(86)90153-X · DOI
- Nikiforuk, 2012, Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats, Behav. Brain Res., 226, 118, 10.1016/j.bbr.2011.09.006 · DOI
- Nikiforuk, 2013, Quetiapine ameliorates stress-induced cognitive inflexibility in rats, Neuropharmacology, 64, 357, 10.1016/j.neuropharm.2012.06.042 · DOI
- Nikiforuk, 2011, Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants, Psychoneuroendocrinology, 36, 28, 10.1016/j.psyneuen.2010.06.001 · DOI
- Okamoto, 2010, Wnt2 expression and signaling is increased by different classes of antidepressant treatments, Biol. Psychiatry, 68, 521, 10.1016/j.biopsych.2010.04.023 · DOI · Paper page
- Pehrson, 2013, Vortioxetine, a novel multimodal antidepressant, modulates GABA and glutamate neurotransmission via serotonergic mechanisms, Eur. Neuropsychopharmacol., 23, S196, 10.1016/S0924-977X(13)70301-8 · DOI
- Pehrson, 2014, Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction, CNS Spectr., 19, 121, 10.1017/S1092852913000540 · DOI · Paper page
- Popoli, 2002, Modulation of synaptic plasticity by stress and antidepressants, Bipolar Disord., 4, 166, 10.1034/j.1399-5618.2002.01159.x · DOI · Paper page
- Popoli, 1997, Long-term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus, Mol. Pharmacol., 51, 19, 10.1124/mol.51.1.19 · DOI
- Pratt, 2008, Modelling prefrontal cortex deficits in schizophrenia: implications for treatment, Br. J. Pharmacol., 153, S465
- Puig, 2010, Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors, J. Neurosci., 30, 2211, 10.1523/JNEUROSCI.3335-09.2010 · DOI · Paper page
- Reppermund, 2011, The relationship of current depressive symptoms and past depression with cognitive impairment and instrumental activities of daily living in an elderly population: the Sydney memory and ageing study, J. Psychiatr. Res., 45, 1600, 10.1016/j.jpsychires.2011.08.001 · DOI · Paper page
- Richter-Levin, 1989, Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission, Brain Res., 477, 404, 10.1016/0006-8993(89)91437-6 · DOI
- Riga, 2013, Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine, Eur. Neuropsychopharmacol., 23, S393, 10.1016/S0924-977X(13)70621-7 · DOI
- Ryan, 2009, Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression, Int. J. Neuropsychopharmacol., 12, 553, 10.1017/S1461145708009607 · DOI · Paper page
- Saletu, 2010, EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression, Clin. EEG Neurosci., 41, 203, 10.1177/155005941004100407 · DOI · Paper page
- Saletu, 1985, Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses, J. Clin. Psychiatry, 46, 45
- Saletu, 1988, Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects, J Clin Psychi, 49, s59
- Saletu, 1992, Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology, Br. J. Clin. Pharmacol., 33, 589, 10.1111/j.1365-2125.1992.tb04087.x · DOI · Paper page
- Saletu, 1996, Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry, J. Neural. Transm., 103, 191, 10.1007/BF01292627 · DOI
- Salin-Pascual, 1997, Effects of venlafaxine in the sleep architecture of rats, Psychopharmacology, 129, 295, 10.1007/s002130050194 · doi:10.1007/s002130050194
- Sanchez, 2007, Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats, Pharmacol. Biochem. Behav., 86, 468, 10.1016/j.pbb.2007.01.006 · DOI
- Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328 · DOI · Paper page
- Schilstrom, 2011, Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-d-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat, Synapse, 65, 357, 10.1002/syn.20853 · DOI · Paper page
- Sebban, 1999, Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission, Br. J. Pharmacol., 128, 1045, 10.1038/sj.bjp.0702894 · DOI · Paper page
- Seu, 2009, Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats, Neuropharmacology, 57, 665, 10.1016/j.neuropharm.2009.08.007 · DOI · Paper page
- Seu, 2009, Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys, Psychopharmacology, 202, 505, 10.1007/s00213-008-1250-4 · DOI · Paper page
- Siepmann, 2003, Effects of sertraline on autonomic and cognitive functions in healthy volunteers, Psychopharmacology, 168, 293, 10.1007/s00213-003-1448-4 · DOI
- Siepmann, 2008, The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers, Pharmacopsychiatry, 41, 146, 10.1055/s-2008-1076724 · DOI
- Song, 2006, Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress, Pharmacol. Biochem. Behav., 83, 186, 10.1016/j.pbb.2006.01.004 · DOI · Paper page
- Stancampiano, 1997, The decrease of serotonin release induced by a tryptophan-free amino acid diet does not affect spatial and passive avoidance learning, Brain Res., 762, 269, 10.1016/S0006-8993(97)00506-4 · DOI
- Staubli, 1994, Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses, Brain Res., 643, 10, 10.1016/0006-8993(94)90003-5 · DOI
- Steffens, 2011, Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study, Am. J. Geriatr. Psychiatry, 19, 4, 10.1097/JGP.0b013e3181d6c245 · DOI · Paper page
- Stewart, 2000, Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity, Psychopharmacology, 148, 217, 10.1007/s002130050045 · DOI
- Tang, 1999, Genetic enhancement of learning and memory in mice, Nature, 401, 63, 10.1038/43432 · DOI · Paper page
- Tarn, 1993, Fluoxetine, amitriptyline and the electroencephalogram, J. Affect Disord., 29, 7, 10.1016/0165-0327(93)90112-W · DOI
- Thome, 2000, cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment, J. Neurosci., 20, 4030, 10.1523/JNEUROSCI.20-11-04030.2000 · DOI · Paper page
- Tiraboschi, 2004, Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades, Neuropsychopharmacology, 29, 1831, 10.1038/sj.npp.1300488 · DOI · Paper page
- Topic, 2008, Extinction-induced "despair” in aged and adult rats: links to neurotrophins in frontal cortex and hippocampus, Neurobiol. Learn. Mem., 90, 519, 10.1016/j.nlm.2008.06.011 · DOI
- Torregrossa, 2012, Chronic corticosterone exposure during adolescence reduces impulsive action but increases impulsive choice and sensitivity to yohimbine in male Sprague-Dawley rats, Neuropsychopharmacology, 37, 1656, 10.1038/npp.2012.11 · DOI
- Vargas, 2014, In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an alzheimer׳s disease model, J. Neurosci., 34, 2191, 10.1523/JNEUROSCI.0862-13.2014 · DOI · Paper page
- Vila-Luna, 2012, Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons, Neuroscience, 202, 384, 10.1016/j.neuroscience.2011.11.053 · DOI
- Vinkers, 2004, Temporal relation between depression and cognitive impairment in old age: prospective population based study, BMJ, 329, 881, 10.1136/bmj.38216.604664.DE · DOI · Paper page
- Valluzzi, 2007, Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks, Behav. Pharmacol., 18, 507, 10.1097/FBP.0b013e3282ee2a91 · DOI · Paper page
- Vas, 2013, Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment, J. Neural. Transm., 120, 169, 10.1007/s00702-012-0847-2 · DOI
- von Engelhardt, 2008, Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks, Neuron, 60, 846, 10.1016/j.neuron.2008.09.039 · DOI · Paper page
- Ward, 2003, Synchronous neural oscillations and cognitive processes, Trends Cogn. Sci., 7, 553, 10.1016/j.tics.2003.10.012 · DOI · Paper page
- Westrich, 2012, In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets, Int. J. Psychiatry Clin. Pract., 5, 47
- Wilson, 2004, Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram, Eur. Neuropsychopharmacol., 14, 367, 10.1016/j.euroneuro.2003.11.004 · DOI
- Yau, 2002, Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats, J. Neurosci., 22, 1436, 10.1523/JNEUROSCI.22-04-01436.2002 · DOI · Paper page
- Zhong, 2011, Differential regulation of the excitability of prefrontal cortical fast-spiking interneurons and pyramidal neurons by serotonin and fluoxetine, PloS One, 6, e16970, 10.1371/journal.pone.0016970 · DOI · Paper page
- Zhou, 1999, Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex, J. Neurophysiol., 82, 2989, 10.1152/jn.1999.82.6.2989 · DOI · Paper page
Cited by
Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.52 · Cited by 307
Cognitive dysfunction in major depressive disorder
Knight, M. J., & Baune, B. T. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000378 · Cited by 207
Prado, C. E., Watt, S., & Crowe, S. F. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9369-5 · Cited by 188
McIntyre, R., Harrison, J., Loft, H., Jacobson, W., & Olsen, C. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw055 · Cited by 185
“The pharmacodynamic mechanisms proposed to mediate the effects of vortioxetine on cognitive dysfunction in patients with MDD are believed to include increased glutamate neurotransmission (via inhibition of gamma-aminobutyric acid [GABA] interneurons expressing 5-HT3 heteroreceptors) and neuroplasticity in brain region…”
BackgroundBaune, B. T., Brignone, M., & Larsen, K. G. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx070 · Cited by 140
Metadata
- Authors
- Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 753
- Pages
- 19-31
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1969903815
- Cited by
- 91
- References
- 49
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. https://app.cochat.ai/papers/10.1016/j.ejphar.2014.07.044
- The paper
- Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C. (2015). Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2014.07.044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.